More efficient and longer lasting glucose-responsive insulin that eliminates the need for people with type 1 diabetes to measure their glucose levels could be a step closer thanks to a Monash University-led project.
The researchers from Monash University, RMIT University, The University of Melbourne and the Baker Institute developed the system to respond to glucose, which current insulin does not.
Co-first author Dr. Rong Xu, from the Monash University Central Clinical School’s Australian Center for Blood Diseases, and Dr. Sukhvir Kaur Bhangu from RMIT University and the University of Melbourne said if it worked in humans, only two injections would be needed per day.
Current insulin therapy requires people to monitor their blood sugar throughout the day and take multiple, carefully calculated doses based on food intake, exercise, stress, illness and other factors.
Some must inject themselves up to five times a day. Continuous glucose monitoring devices remove, or at least reduce, the need for finger pricks, and insulin pumps can automatically deliver insulin, but they are very expensive and still are not always able to calculate the correct amount of insulin to be given.
The multidisciplinary team developed a new “artificial pancreas system” using phytoglycogen nanoparticles, which are chains on glucose molecules dubbed a “nanosugar platform” as they are made of glucose, to deliver and release insulin in response to glucose levels in the blood.
This engineered nanosugar platform enabled rapid and sustained glucose-responsive insulin delivery, which was longer lasting and smarter than other systems.
Dr. Xu said it required only one injection every 12 hours and self-regulated. “This system would mean fewer injections and, potentially, no need to measure glucose,” Dr. Xu said.
The research emerged from an NHMRC Ideas Grant awarded to co-lead author and Head of Monash University’s Australian Center for Blood Diseases NanoBiotechnology Laboratory, Professor Christoph Hagemeyer, co-lead author and RMIT Associate Professor Francesca Cavalieri, and co-author Professor Frank Caruso at the University of Melbourne to develop this revolutionary type of insulin.
Professor Hagemeyer said more research was needed but the results were promising. He said the nanosugar platform was biodegradable, which enabled rapid and extended glucose control in two different models of type 1 diabetes with a single injection.
“The nanosugar particles are engineered to control insulin release and absorption through the lymphatic system into the blood,” he said.
Professor Cavalieri said the research team, which includes several clinicians, now hoped to secure funding to continue the project and eventually undertake clinical trials. “This new method is not only efficient, it’s biodegradable and uses natural methods, which significantly reduces the chances of adverse affects or immune reactions,” she said.

News
Advancing Pancreatic Cancer Treatment with Nanoparticle-Based Chemotherapy
Pancreatic cancer, a particularly lethal form of cancer and the fourth leading cause of cancer-related deaths in the western world, often remains undiagnosed until its advanced stages due to a lack of early symptoms. [...]
The ‘jigglings and wigglings of atoms’ reveal key aspects of COVID-19 virulence evolution
Richard Feynman famously stated, "Everything that living things do can be understood in terms of the jigglings and wigglings of atoms." This week, Nature Nanotechnology features a study that sheds new light on the evolution of the coronavirus [...]
AI system self-organizes to develop features of brains of complex organisms
Cambridge scientists have shown that placing physical constraints on an artificially-intelligent system—in much the same way that the human brain has to develop and operate within physical and biological constraints—allows it to develop features [...]
How Blind People Recognize Faces via Sound
Summary: A new study reveals that people who are blind can recognize faces using auditory patterns processed by the fusiform face area, a brain region crucial for face processing in sighted individuals. The study employed [...]
Treating tumors with engineered dendritic cells
Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center (Heidelberg) have developed a novel immunotherapy that does not require knowledge of a tumor's antigenic makeup. The new results may pave the way [...]
Networking nano-biosensors for wireless communication in the blood
Biological computing machines, such as micro and nano-implants that can collect important information inside the human body, are transforming medicine. Yet, networking them for communication has proven challenging. Now, a global team, including EPFL [...]
Popular Hospital Disinfectant Ineffective Against Common Superbug
Research conducted during World Antimicrobial Awareness Week examines the effects of employing suggested chlorine-based chemicals to combat Clostridioides difficile, the leading cause of antibiotic-related illness in healthcare environments worldwide. A recent study reveals that a [...]
Subjectivity and the Evolution of AI Philosophy
An Historical Overview of the Philosophy of Artificial Intelligence by Anton Vokrug Many famous people in the philosophy of technology have tried to comprehend the essence of technology and link it to society and human [...]
How Lockdowns Shaped the Virus: AI Uncovers COVID-19’s Evolutionary Secrets
A new research study shows that human behavior, like lockdowns, influences the evolution of COVID-19, leading to strains that are more transmissible earlier in their lifecycle. Using artificial intelligence technology and mathematical modeling, a research [...]
Groundbreaking therapy approved: chances of cure for 7000 diseases:
Hereditary diseases are usually not curable. Now, however, an epochal turning point is taking place in medicine: For the first time ever, a therapy with the CRISPR/Cas9 gene scissors has received approval. According to [...]
Uncovering the Genetic Mystery: Why Some Never Show COVID-19 Symptoms
New study shows that common genetic variation among people is responsible for mediating SARS-CoV-2 asymptomatic infection. Have you ever wondered why some people never became sick from COVID-19? A study published recently in the journal Nature shows that common [...]
AI maps tumor geography for tailored treatments
Researchers have integrated AI approaches from satellite mapping and community ecology to develop a tool to interpret data obtained from tumor tissue imaging, with the aim of implementing a more individualized approach to cancer care. [...]
Lung cancer cells’ ‘memories’ suggest new strategy for improving treatment
A new understanding of lung cancer cells' "memories" suggests a new strategy for improving treatment, Memorial Sloan Kettering Cancer Center (MSK) researchers have found. Research from the lab of cancer biologist Tuomas Tammela, MD, Ph.D. [...]
Artificial sensor similar to a human fingerprint can recognize fine fabric textures
An artificial sensory system that is able to recognize fine textures—such as twill, corduroy and wool—with a high resolution, similar to a human finger, is reported in a Nature Communications paper. The findings may help improve the subtle [...]
How tiny hinges bend the infection-spreading spikes of a coronavirus
A coronavirus uses protein "spikes" to grab and infect cells. Despite their name, those spikes aren't stiff and pointy. They're shaped like chicken drumsticks with the meaty part facing out, and the meaty part [...]
A Scientist Says the Singularity Will Happen by 2031
“The singularity,” the moment where AI is no longer under human control, is less than a decade away—according to one AI expert. More resources than ever are being poured into the pursuit of artificial [...]